GNAS and urinary bladder cancer: GSP can reverse EMT by inhibiting the TGF-β signaling pathway, effectively inhibiting the migration and invasion of bladder cancer (BC) cells (Yang et al., 2021b), suggesting that GSP can be used as a potential chemotherapy drug for BC.